Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001087294-13-000009
Filing Date
2013-08-09
Accepted
2013-08-09 17:07:06
Documents
10
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cpix2013630-10q.htm 10-Q 505372
2 EX 31.1 cpix2013630-exhibit311.htm EX-31.1 15949
3 EX 31.2 cpix2013630-exhibit312.htm EX-31.2 15958
4 EX 32.1 cpix2013630-exhibit321.htm EX-32.1 8109
  Complete submission text file 0001087294-13-000009.txt   4442525

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cpix-20130630.xml EX-101.INS 382232
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20130630.xsd EX-101.SCH 26299
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20130630_cal.xml EX-101.CAL 45218
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20130630_def.xml EX-101.DEF 128858
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20130630_lab.xml EX-101.LAB 313322
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20130630_pre.xml EX-101.PRE 168515
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 131027477
SIC: 2834 Pharmaceutical Preparations